Search Results - "Goldstein, S C"

B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality by Saliba, R M, Sarantopoulos, S, Kitko, C L, Pawarode, A, Goldstein, S C, Magenau, J, Alousi, A M, Churay, T, Justman, H, Paczesny, S, Reddy, P, Couriel, D R

“…Biological markers for risk stratification of chronic GvHD (cGvHD) could improve the care of patients undergoing allogeneic hematopoietic stem cell…”
Get full text

High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT by Tizon, R, Frey, N, Heitjan, D F, Tan, K S, Goldstein, S C, Hexner, E O, Loren, A, Luger, S M, Reshef, R, Tsai, D, Vogl, D, Davis, J, Vozniak, M, Fuchs, B, Stadtmauer, E A, Porter, D L

“…Idiopathic Pneumonia Syndrome (IPS) is a common complication after allo-SCT and results in high mortality rates. Conventional treatment for IPS typically…”
Get full text

Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas by Paralkar, V R, Nasta, S D, Morrissey, K, Smith, J, Vassilev, P, Martin, M E, Goldstein, S C, Loren, A, Rook, A H, Kim, E J, Porter, D L

“…Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of non-Hodgkin lymphomas that are considered incurable. The role of allogeneic hematopoietic SCT…”
Get full text

Has allogeneic stem cell cryopreservation been given the 'cold shoulder'? An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation by FREY, N. V, LAZARUS, H. M, GOLDSTEIN, S. C

“…Donor stem cells for allogeneic transplant traditionally are collected and transfused 'fresh' into the recipient on the day of transplant; alternatively such…”
Get full text

Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD by Rager, A, Frey, N, Goldstein, S C, Reshef, R, Hexner, E O, Loren, A, Luger, S M, Perl, A, Tsai, D, Davis, J, Vozniak, M, Smith, J, Stadtmauer, E A, Porter, D L

“…Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-α are important mediators…”
Get full text

Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance by Ahmadi, T, McQuade, J, Porter, D, Frey, N, Loren, A W, Goldstein, S C, Svoboda, J, Stadtmauer, E, Schuster, S J, Nasta, S D

“…We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or…”
Get full text

Standing, legal injury without harm, and the public/private divide by Goldstein, William S C

“…Legal injury without harm is a common phenomenon in the law. Historically, legal injury without harm was actionable for at least nominal damages, and sometimes…”
Get full text

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma by ANDREADIS, C, SCHUSTER, S. J, DOWNS, L. H, MANGAN, P. A, CUNNINGHAM, K. A, HUMMEL, K. A, GIMOTTY, P. A, SIEGEL, D. L, GLATSTEIN, E, STADTMAUER, E. A, CHONG, E. A, SVOBODA, J, LUGER, S. M, PORTER, D. L, TSAI, D. E, NASTA, S. D, ELSTROM, R. L, GOLDSTEIN, S. C

“…Although follicular lymphoma (FL) is generally responsive to conventional-dose chemotherapy, improved survival in patients with this disease has been difficult…”
Get full text

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation by LOREN, A. W, LUGER, S. M, GREEN, J, EMERSON, S. G, PORTER, D. L, STADTMAUER, E. A, TSAI, D. E, SCHUSTER, S, NASTA, S. D, GOLDSTEIN, S. C, PERL, A, ORLOFF, G, OLIVER, J. C

“…Nonmyeloablative stem cell transplantation (NST) harnesses the graft-versus-tumor effect while minimizing regimen-related toxicity, and can result in donor…”
Get full text

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency by BALLESTER, O. F, TUMMALA, R, ZORSKY, P, SAEZ, R, ELFENBEIN, G. J, JANSSEN, W. E, FIELDS, K. K, HIEMENZ, J. W, GOLDSTEIN, S. C, PERKINS, J. B, SULLIVAN, D. M, ROSEN, R, SACKSTEIN, R

“…Six patients with multiple myeloma and chronic renal insufficiency (serum creatinine >3.0 mg/dl), including four on dialysis, received high-dose busulfan and…”
Get full text

Programmable matter by Goldstein, S.C., Campbell, J.D., Mowry, T.C.

“…In the past 50 years, computers have shrunk from room-size mainframes to lightweight handhelds. This fantastic miniaturization is primarily the result of…”
Get full text

Molecular electronics: from devices and interconnect to circuits and architecture by Stan, M.R., Franzon, P.D., Goldstein, S.C., Lach, J.C., Ziegler, M.M.

“…As the dominating CMOS technology is fast approaching a "brick wall," new opportunities arise for competing solutions. Nanoelectronics has achieved several…”
Get full text

PipeRench: a reconfigurable architecture and compiler by Goldstein, S.C., Schmit, H., Budiu, M., Cadambi, S., Moe, M., Taylor, R.R.

“…With the proliferation of highly specialized embedded computer systems has come a diversification of workloads for computing devices. General-purpose…”
Get full text

Proteinuria and renal insufficiency three years after treatment of gastric lymphoma by Markowitz, Glen S., Goldstein, Carl S., D'Agati, Vivette D.

Get full text

Critical Pedagogy in a Bilingual Special Education Classroom by Goldstein, Barbara S. C

“…This article describes the application of critical pedagogical principles in a primary-level bilingual special day class for Latino children with limited…”
Get more information

Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive induction chemotherapy regimen for patients with high‐risk multiple myeloma by BALLESTER, O. F., MOSCINSKI, L. C., FIELDS, K. K., HIEMENZ, J. W., ZORSKY, P. E., GOLDSTEIN, S. C., SABA, H. I., SPIERS, A. S. D., KRONISH, L., SULLIVAN, P., ELFENBEIN, G. J.

“…We evaluated toxicities and responses to a novel, dose intensive and time sequenced, chemotherapy programme (DC‐IE) in 45 patients with high‐risk myeloma…”
Get full text

Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer by Fields, K K, Elfenbein, G J, Perkins, J B, Ballester, O F, Goldstein, S C, Heimenz, J W, Saez, R A, Sullivan, D M, Partyka, J S, Kronish, L A

“…We have explored several novel high-dose combinations in an attempt to increase antitumor activity while decreasing treatment-related toxicity. From October…”
Get more information

Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients by Goldstein, Carl S., Bomalaski, John S., Zurier, Robert B., Neilson, Eric G., Douglas, Steven D.

“…Analysis of peritoneal macrophages in continuous ambulatory dialysis patients. Peritoneal macrophages (PMC) from patients undergoing continuous ambulatory…”
Get full text

Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery by Ballester, O F, Agaliotis, D P, Hiemenz, J W, Janssen, W E, Fields, K K, Zorksy, P E, Goldstein, S C, Perkins, J B, Elfenbein, G J

“…In a phase I-II study, we evaluated toxicities, tolerability, pace of engraftment, and tumor responses to high-dose bulsulfan and cyclophosphamide followed by…”
Get more information

Nonphotolithographic nanoscale memory density prospects by DeHon, A., Goldstein, S.C., Kuekes, P.J., Lincoln, P.

“…Technologies are now emerging to construct molecular-scale electronic wires and switches using bottom-up self-assembly. This opens the possibility of…”
Get full text